Qube Research & Technologies (QRT)
TENX icon

Qube Research & Technologies (QRT)’s Tenax Therapeutics TENX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.25M Buy
429,893
+401,608
+1,420% +$5.13M 0.01% 1526
2026
Q1 		$452K Buy
+28,285
New +$383K ﹤0.01% 2770
2024
Q3 		– Sell
-4,407
Closed -$13.4K – 4099
2024
Q2 		$13.4K Hold
4,407
– – ﹤0.01% 2935
2024
Q1 		$18.7K Buy
4,407
+4,401
+73,350% +$33.8K ﹤0.01% 3708
2023
Q4 		$137 Buy
+6
New +$144 ﹤0.01% 4003

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TENX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Tenax Therapeutics (TENX) stake by 1,420% in Q2 2026, buying an estimated $5.13M and bringing the position to 429,893 shares worth $6.25M. The position accounts for 0.01% of the portfolio, ranked #1526.

Qube Research & Technologies (QRT) first reported a position in TENX in Q4 2023 and has held it in 5 quarters since. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Qube Research & Technologies (QRT) held 429,893 shares of Tenax Therapeutics worth $6.25M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 401,608 Tenax Therapeutics shares in Q2 2026, an estimated $5.13M.
  • Tenax Therapeutics made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1526 holding.
  • Qube Research & Technologies (QRT) first reported a position in Tenax Therapeutics in Q4 2023 and has held it in 5 quarters since.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.